Northwestern University Transplant Research Collaborative (NUTORC), Comprehensive Transplant Center (CTC), Feinberg School of Medicine, Northwestern University, Chicago, IL.
Division of Hepatology, Department of Medicine, Feinberg School of Medicine, Chicago, IL.
Transplantation. 2019 Dec;103(12):2531-2538. doi: 10.1097/TP.0000000000002733.
Despite lower socioeconomic status, Hispanics in the United States paradoxically maintain equal or higher average survival rates compared to non-Hispanic Whites (NHW).
We used multivariable Cox regression to assess whether this "Hispanic paradox" applies to patients with liver cirrhosis using a retrospective cohort of twenty 121 patients in a Chicago-wide electronic health record database.
Our study population included 3279 (16%) Hispanics, 9150 (45%) NHW, 4432 (22%) African Americans, 529 (3%) Asians, and 2731 (14%) of other races/ethnic groups. Compared to Hispanics, NHW (hazard ratio [HR] 1.26; 95% confidence interval [CI], 1.16-1.37), African American (HR 1.26; 95% CI, 1.15-1.39), and other races/ethnic groups (HR 1.55; 95% CI, 1.40-1.71) had an increased risk of death despite adjustment for age, sex, insurance status, etiology of cirrhosis, and comorbidities. On stratified analyses, a mortality advantage for Hispanics compared to NHW was seen for alcohol cirrhosis (HR for NHW 1.35; 95% CI, 1.19-1.52), hepatitis B (HR for NHW 1.35; 95% CI, 0.98-1.87), hepatitis C (HR for NHW 1.21; 95% CI, 1.06-1.38), and nonalcoholic steatohepatitis (HR for NHW 1.14; 95% CI, 0.94-1.39). There was no advantage associated with Hispanic race over NHW in cases of hepatocellular carcinoma or cholestatic liver disease.
Hispanic patients with cirrhosis experience a survival advantage over many other racial groups despite adjustment for multiple covariates.
尽管社会经济地位较低,美国的西班牙裔人口的平均生存率却与非西班牙裔白人(NHW)相等或更高,这种情况存在矛盾。
我们使用多变量 Cox 回归分析,使用芝加哥范围内电子健康记录数据库中的 20,121 例回顾性队列研究评估这种“西班牙裔悖论”是否适用于肝硬化患者。
我们的研究人群包括 3279 名(16%)西班牙裔、9150 名(45%)NHW、4432 名(22%)非裔美国人、529 名(3%)亚洲人和 2731 名(14%)其他种族/族裔群体。与西班牙裔相比,NHW(风险比 [HR] 1.26;95%置信区间 [CI],1.16-1.37)、非裔美国人(HR 1.26;95% CI,1.15-1.39)和其他种族/族裔群体(HR 1.55;95% CI,1.40-1.71)尽管调整了年龄、性别、保险状况、肝硬化病因和合并症,但死亡风险仍增加。在分层分析中,与 NHW 相比,西班牙裔在酒精性肝硬化(NHW 的 HR 为 1.35;95% CI,1.19-1.52)、乙型肝炎(NHW 的 HR 为 1.35;95% CI,0.98-1.87)、丙型肝炎(NHW 的 HR 为 1.21;95% CI,1.06-1.38)和非酒精性脂肪性肝炎(NHW 的 HR 为 1.14;95% CI,0.94-1.39)方面具有生存优势。但是,在肝细胞癌或胆汁淤积性肝病方面,西班牙裔种族并未显示出比 NHW 更高的优势。
尽管调整了多个协变量,肝硬化的西班牙裔患者的生存率仍优于许多其他种族群体。